Pulmonx (LUNG) Asset Writedowns and Impairment (2019 - 2025)
Pulmonx's (LUNG) quarterly Asset Writedowns and Impairment came in at $72000.0 in Q3 2025, up 149.32% year-over-year from $28879.1 in Q3 2024, and up 244.0% quarter-over-quarter from -$50000.0 in Q2 2025.
Powered by 
Analysis
Pulmonx (LUNG) Asset Writedowns and Impairment (2019 - 2025) Analysis & Trends
Pulmonx (LUNG) has reported Asset Writedowns and Impairment for 7 consecutive years, with $72000.0 the latest figure, recorded in Q3 2025.
- On a quarterly basis, Asset Writedowns and Impairment rose 149.32% year-over-year to $72000.0 in Q3 2025; TTM through Sep 2025 was -$24000.0, a 101.83% decrease from a year earlier, with the FY2024 full-year figure at $1.7 million, up 238.66% from the prior year.
- Asset Writedowns and Impairment was $72000.0 for Q3 2025 at Pulmonx, up from -$50000.0 in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $1.7 million in Q2 2024 and troughed at -$405000.0 in Q4 2023.
- A 5-year average of $215055.6 and a median of $166500.0 in 2022 frame the typical range for Asset Writedowns and Impairment.
- Across the five-year window, Asset Writedowns and Impairment sank 338.24% in 2023 and surged 1488.79% in 2024, its largest moves.
- Over 5 years, Asset Writedowns and Impairment stood at $214000.0 in 2021, then dropped by 20.56% to $170000.0 in 2022, then slumped by 338.24% to -$405000.0 in 2023, then jumped by 63.95% to -$146000.0 in 2024, then surged by 149.32% to $72000.0 in 2025.
- The last three Asset Writedowns and Impairment figures came in at $72000.0 (Q3 2025), -$50000.0 (Q2 2025), and -$46000.0 (Q1 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Pulmonx | 75.94 Mn | 6.19 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 72,000.00 |
| Jun 30, 2025 | -50,000.00 |
| Mar 31, 2025 | -46,000.00 |
| Sep 30, 2024 | -146,000.00 |
| Jun 30, 2024 | 1.70 Mn |
| Mar 31, 2024 | 163,000.00 |
| Dec 31, 2023 | -405,000.00 |
| Sep 30, 2023 | 532,000.00 |
| Jun 30, 2023 | 107,000.00 |
| Mar 31, 2023 | 273,000.00 |
| Dec 31, 2022 | 170,000.00 |
| Sep 30, 2022 | 204,000.00 |
| Jun 30, 2022 | 65,000.00 |
| Mar 31, 2022 | 46,000.00 |
| Dec 31, 2021 | 214,000.00 |
| Sep 30, 2021 | 307,000.00 |
| Jun 30, 2021 | 212,000.00 |
| Mar 31, 2021 | 453,000.00 |
| Jun 30, 2020 | 2.94 Mn |
| Mar 31, 2020 | 95,000.00 |